A Retrospective Review of 12 Patients with Trichotillomania Treated in a Psychodermatology Service

    James Michael Carr, Helen Mortimer, Katherine Martin, Manjit Kaur, J. M. R. Goulding
    Image of study
    TLDR The review found that individualized treatment and teamwork are important for trichotillomania, and patients who followed through with treatment often improved.
    The retrospective review focused on 12 patients with trichotillomania, an obsessive-compulsive disorder characterized by hair pulling, treated at a psychodermatology service between 2011 and 2016. The patients, 11 females and 1 male, ranged in age from 23 to 71, with various ethnic backgrounds. Most were referred by dermatologists, and many had comorbid conditions such as depression, anxiety, learning difficulties, and other physical disorders. Treatment strategies varied, including referrals to mental health services, in-house psychology, and recommendations for selective serotonin reuptake inhibitors (SSRIs). Habit reversal techniques were also suggested. The study found a high rate of appointment defaulting (58%) compared to other diagnoses within the service (19.5%). However, improvements were noted in patients who engaged with the services. The authors emphasized the need for individualized treatment approaches and multidisciplinary collaboration, highlighting that cognitive behavioral therapy with habit reversal is the first-line treatment, while pharmacotherapy is considered a second-line option due to limited evidence of efficacy.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    3 / 3 results

      community C’est terrible - at my wits end

      in Female  448 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  148 upvotes 2 years ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

    Similar Research

    6 / 1000+ results